ᐅNorditropin Simplexx For Sale Australia, Omnitrope 5.8mg Vial Price
→ CLICK TO ENTER OUR STORE ←
Omnitrope pen® (Somatropin 150iu kit - 5 x 10mg(30iu) 1.5ml HGH cartridges Injection) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information description, Omnitrope pen® (Somatropin 150iu kit - 5 x 10mg(30iu) 1.5ml HGH cartridges Injection) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information side effects, Omnitrope pen® (Somatropin 150iu kit - 5 x 10mg(30iu) 1.5ml HGH cartridges Injection) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information price, Omnitrope pen® (Somatropin 150iu kit - 5 x 10mg(30iu) 1.5ml HGH cartridges Injection) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information substance Omnitrope pen Omnitrope Drug Description OMNITROPE® (somatropin [rDNA origin]) Injection DRUG DESCRIPTION Omnitrope® (somatropin-[rDNA] origin) is a polypeptide hormone of recombinant DNA origin. It has 191 amino acid residues and a molecular weight of 22,125 daltons. The amino acid sequence of the product is identical to that of human growth hormone of pituitary origin (somatropin). Omnitrope® is synthesized in a strain of. Escherichia coli that has been modified by the addition of the gene for human growth hormone. Omnitrope® Cartridge is a clear, colorless, sterile solution for subcutaneous injection. Omnitrope® for Injection is a lyophilized powder that is reconstituted for subcutaneous injection. Figure 1: Schematic amino acid sequence of human growth hormone including the disulfide bonds Each Omnitrope® Cartridge or vial contains the following (see Table 4 ): Table 4. Contents of Omnitrope® Cartridges and Vial Product Cartridge 5 mg/1.5 mL Cartridge 10 mg/1.5 mL For Injection 5.8 mg/vial Component Somatropin 5 mg 10 mg 5.8 mg Disodium hydrogen phosphate heptahydrate 1.3 mg 1.70 mg 2.09 mg Sodium dihydrogen phosphate dihydrate 1.6 mg 1.35 mg 0.56 mg Poloxamer 188 3.0 mg 3.0 mg - Mannitol 52.5 mg - - Glycine - 27.75 mg 27.6 mg Benzyl alcohol 13.5 mg - - Phenol - 4.50 mg - Water for Injection to make 1.5 mL to make 1.5 mL - Diluent (vials only) Bacteriostatic Water for Injection Water for injection to make 1.14 mL Benzyl alcohol 17 mg What are the possible side effects of somatropin? If you have Prader-Willi syndrome, call your doctor promptly if you develop signs of lung or breathing problems such as shortness of breath, coughing, or new or increased snoring. Rare cases of serious breathing problems have occurred in patients with Prader-Willi syndrome who use somatropin. Get emergency medical help if you have any of these signs of an allergic reaction : hives; difficult breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious Side Effects Omnitrope pen® (Somatropin 150iu kit - 5 x 10mg(30iu) 1.5ml HGH cartridges Injection) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information: severe pain in your upper stomach spreading to your... Omnitrope INDICATIONS Pediatric Patients Omnitrope® (somatropin [rDNA origin] injection) is indicated for the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone (GH). Omnitrope® [somatropin (rDNA origin) injection] is indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi Syndrome (PWS). The diagnosis of PWS should be confirmed by appropriate genetic testing. Omnitrope® [somatropin (rDNA origin) injection] is indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to manifest catch-up growth by age 2 years. Omnitrope® (somatropin [rDNA origin] injection) is indicated for the treatment of idiopathic short stature (ISS), also called non-growth hormone-deficient short stature, defined by height standard deviation score (SDS) ≤ -2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, in pediatric patients whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature that should be observed or treated by other means. Adult Patients Omnitrope® (somatropin [rDNA origin] injection) is indicated for the replacement of endogenous GH in adults with growth hormone deficiency (GHD) who meet either of the following two criteria
Omnitrope® [somatropin (rDNA origin) injection] is indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to manifest catch-up growth by age 2 years.